Back to search

National and Kapodistrian University of Athens

Η κλινική σημασία της έκφρασης του μεταγραφικού παράγοντα PROSPERO HOMEOBOX-1 (PROX1) στον καρκίνο του πνεύμονα

Abstract

dc:description

Background/Objectives: PROX1 (prospero homeobox 1) is a transcription factor involved in lymphangiogenesis and cellular differentiation. Its role in cancer biology appears to be highly context-dependent, with it exhibiting both tumor-promoting and -suppressive functions across various malignancies. Nonetheless, the clinical significance of PROX1 expression in non-small cell lung cancer (NSCLC) remains poorly elucidated. The objective of this study is to evaluate the immunohistochemical expression of PROX1 in NSCLC, specifically in the adenocarcinoma and squamous cell carcinoma subtypes, and to assess its correlation with clinicopathologic features and overall survival (OS). Methods: This retrospective study included surgically resected specimens from 121 patients with histologically confirmed NSCLC. PROX1 expression was assessed via immunohistochemistry on formalin-fixed, paraffin-embedded specimens. Staining intensity (graded 0- 3) and the percentage of positive tumor cells were recorded. Correlations with histological subtype, tumor characteristics, and OS were analyzed using chi-square tests, one-way ANOVA, and Kaplan-Meier survival analysis with log-rank testing. Results: Low PROX1 intensity (level 1) was significantly associated with P63 positivity (p =0.028), while high PROX1 intensity (level 3) correlated with nodal metastasis to station 3 (S3+) (p =0.025). Additionally, alveolar-pattern adenocarcinomas exhibited intermediate PROX1 expression (26-50%) (p =0.010). Although PROX1 positivity did not differ among mucinous and non-mucinous adenocarcinomas (p =0.152), its distribution across defined expression subgroups was statistically significant (p =0.002). Tumors with a larger maximum tumor diameter were associated with low PROX1 expression (0-24%) (p =0.026). PROX1 expression was not independently associated with OS (p >0.05). Factors significantly associated with improved OS included age <50 years, female sex, the absence of necrosis, < 10 positive lymph nodes, a lymph node ratio < 0.5, and the absence of extensive nodal involvement in stations 5, 10, 11 and 12. Conclusions: PROX1 expression shows variable associations with histologic subtypes and nodal metastases in NSCLC, but does not independently predict OS. Its pattern suggests a potential role in tumor differentiation and lymphatic dissemination, warranting further investigation in lung cancer biology.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ntikoudi, Evangelia
  • Ντικούδη, Ευαγγελία

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/60797

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ntikoudi, Evangelia; Ντικούδη, Ευαγγελία. Η κλινική σημασία της έκφρασης του μεταγραφικού παράγοντα PROSPERO HOMEOBOX-1 (PROX1) στον καρκίνο του πνεύμονα. National and Kapodistrian University of Athens, 2026. http://hdl.handle.net/10442/hedi/60797